Orteq

About:

Orteq is a medical device company that develops and commercializes bioengineering solutions for orthopaedic injuries.

Website: http://orteq.com

Twitter/X: Orteq

Top Investors: Kensey Nash Corporation, Matignon Technologies

Description:

Orteq was established in 2005 to develop and commercialize bioengineering solutions for orthopaedic injuries. Orteq has developed a biodegradable, biocompatible polymer implant, Actifit, specifically designed to promote tissue ingrowth and regeneration in the meniscus, a fibrocartilage cushion in the knee. The company develops innovative healthcare products for the arthroscopic sports medicine surgeon that encourage the body’s own natural healing process. Orteq is headquartered in London.

Total Funding Amount:

8M GBP

Estimated Revenue Range:

$50M to $100M

Headquarters Location:

London, England, United Kingdom

Founded Date:

2005-01-01

Contact Email:

info(AT)orteq.com

Founders:

Number of Employees:

501-1000

Last Funding Date:

2011-01-08

IPO Status:

Private

Industries:

© 2025 bioDAO.ai